NYBC Ventures (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Boston

NYBC Ventures is a $50 million invesment arm operated by the New York Blood Center in USA

Average round investment:44M USD
Average number per year:1.0
Distribution: 2026 (1)2025 (1)2024 (1)
Portfolio companies: Netherlands VitestroUnited Kingdom Cellular Origins
Mostly invests in: Netherlands Netherlands (2) Manufacturing (3)

3 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to NYBC Ventures

Name Criteria
Netherlands Committed Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services, Biotech, Robotics
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fine Structure Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom ALSA Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Yamaha Motor Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Robotics
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States The Nature Conservancy
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Aidan Gomez
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Labcorp
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Netherlands, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland kineo finance
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Health services, Software Services, Robotics
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Move Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Robotics
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top